Evidence map›Paper›PMID 31984762›Full record

ArticleClinical trials (London, England)2020

Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial.

Adam R Glassman, Wesley T Beaulieu, Cynthia R Stockdale, Roy W Beck, Neil M Bressler, Leanne T Labriola, Michele Melia, Kristina Oliver, Jennifer K Sun

Registry-linked trialAbstract read
In one paragraph

Article in Clinical trials (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01489189 (Prompt Panretinal Photocoagulation Versus Intravitreal Ranibizumab With Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy), which is not on this map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01489189 phase3completednot on this map

Prompt Panretinal Photocoagulation Versus Intravitreal Ranibizumab With Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

TypeinterventionalSponsorJaeb Center for Health ResearchRan2012 to 2018Enrolled305ConditionsProliferative Diabetic RetinopathyArmsPrompt Panretinal Photocoagulation, 0.5-mg Ranibizumab, Deferred panretinal photocoagulation
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Strategies to improve retention in randomised trials.The Cochrane database of systematic reviews · 2021
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adam R GlassmanJaeb Center for Health Research, Tampa, FL, USA.
Wesley T BeaulieuJaeb Center for Health Research, Tampa, FL, USA.ORCID 0000-0002-0082-1242
Cynthia R StockdaleJaeb Center for Health Research, Tampa, FL, USA.
Roy W BeckJaeb Center for Health Research, Tampa, FL, USA.
Neil M BresslerWilmer Eye Institute, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Leanne T LabriolaDepartment of Ophthalmology, Carle Foundation Hospital, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Michele MeliaJaeb Center for Health Research, Tampa, FL, USA.
Kristina OliverSoutheastern Retina Associates, Knoxville, TN, USA.
Jennifer K SunBeetham Eye Institute, Joslin Diabetes Center, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Funding

DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK COORDINATING CENTERU10EY014231 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI GLASSMAN, ADAM R · 2002 to 2018
$91.2M
DRCR Retina NetworkUG1EY014231 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI Adam R Glassman, DANIEL F MARTIN · 2019 to 2026
$75.4M
Diabetic Retinopathy Clinical Research Network Chair GrantU10EY023207 · NEI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI JAMPOL, LEE M · 2014 to 2018
$1.8M
Diabetic Retinopathy Clinical Research Network Operations CenterU10EY018817 · NEI · JOHNS HOPKINS UNIVERSITY · PI BRESSLER, NEIL MICHAEL · 2009 to 2013
$769k
NEI NIH HHS U10 EY014231NEI NIH HHS U10 EY018817NEI NIH HHS U10 EY023207NEI NIH HHS UG1 EY014231
6 · The paper itself

Abstract

BACKGROUND/

aimsIn clinical trials, participant retention is critical to reduce bias and maintain statistical power for hypothesis testing. Within a multi-center clinical trial of diabetic retinopathy, we investigated whether regular phone calls to participants from the coordinating center improved long-term participant retention.

methodsAmong 305 adults in the Diabetic Retinopathy Clinical Research Retina Network Protocol S randomized trial, 152 participants were randomly assigned to receive phone calls at baseline, 6 months, and annually through 3 years (annual contact group) while 153 participants were assigned to receive a phone call at baseline only (baseline contact group). All participants could be contacted if visits were missed. The main outcomes were visit completion, excluding deaths, at 2 years (the primary outcome time point) and at 5 years (the final time point).

resultsAt baseline, 77% (117 of 152) of participants in the annual contact group and 76% (116 of 153) in the baseline contact group were successfully contacted. Among participants in the annual contact group active at each annual visit (i.e. not dropped from the study or deceased), 85% (125 of 147), 79% (108 of 136), and 88% (110 of 125) were contacted successfully by telephone around the time of the 1-, 2-, and 3-year visits, respectively. In the annual and baseline contact groups, completion rates for the 2-year primary outcome visit were 88% (129 of 147) versus 87% (125 of 144), respectively, with a risk ratio of 1.01 (95% confidence interval: 0.93-1.10,

conclusionRegular phone calls from the coordinating center to participants during follow-up in this randomized clinical trial did not improve long-term participant retention.

Indexed as

Patient ParticipationRandomized Controlled Trials as TopicReminder SystemsTelephoneAdultFemaleHumansLost to Follow-UpMaleMiddle AgedResearch DesignRetention in Careloss to follow-upmulti-center randomized clinical trialRetention

Identifiers

PMID31984762
PMCPMC7673295

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.